Innovative financing for global health issues discussed at Nairobi meeting

As more countries prepare to introduce a voluntary travel tax to help fight HIV/AIDS and other diseases worldwide, Philippe Douste-Blazy, chair of UNITAID and a U.N. special advisor on innovative development financing said at a recent event in Nairobi, Kenya, that "the airline levy gives participating developing nations an opportunity to contribute to treatment in their countries rather than depending on handouts from the developed world," the Standard reports. "Cote d'Ivoire, Niger, Madagascar and Mauritius are applying the airline levy, while Benin, Burkina Faso and Kenya have said they will introduce it," according to the Standard. 

Douste-Blazy said that the current financial downturn could make it "very difficult" to get Millennium Development Goal funding from governments, "so innovative methods of financing the fight against these diseases must be sought."

Kenyan Health Minister Beth Mugo at the meeting said that African governments should play a bigger role in health financing, "We need long-term financing for health and we must put pressure on our leaders to implement their Abuja pledge to dedicate 15 percent of the budget to health," Mugo said. "Few are doing so. In Kenya for example, only seven percent of our national budget is spent on health."

The Standard reports that "[p]articipants also stressed the urgent need for Africa's public health systems to become more efficient" (Orengo, 10/18).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024